Walleye Capital
PAHC icon

Walleye Capital’s Phibro Animal Health PAHC Stock Holding History

Walleye Capital’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,755
Closed -$1.54M – 5070
2026
Q1 		$1.54M Sell
27,755
-38,436
-58% -$1.83M 0.01% 1687
2025
Q4 		$2.47M Buy
66,191
+14,713
+29% +$598K 0.01% 1712
2025
Q3 		$2.08M Buy
51,478
+38,578
+299% +$1.27M 0.01% 1551
2025
Q2 		$329K Buy
+12,900
New +$281K ﹤0.01% 2982
2025
Q1 		– Sell
-20,095
Closed -$422K – 4900
2024
Q4 		$422K Buy
+20,095
New +$465K ﹤0.01% 3126
2024
Q2 		– Sell
-15,666
Closed -$203K – 5889
2024
Q1 		$203K Sell
15,666
-5,112
-25% -$61.3K ﹤0.01% 3966
2023
Q4 		$241K Buy
+20,778
New +$235K ﹤0.01% 3546
2023
Q1 		– Sell
-28,597
Closed -$383K – 4257
2022
Q4 		$383K Sell
28,597
-71,292
-71% -$956K 0.01% 1626
2022
Q3 		$1.33M Buy
99,889
+35,755
+56% +$617K 0.03% 775
2022
Q2 		$1.23M Buy
64,134
+29,749
+87% +$563K 0.03% 551
2022
Q1 		$686K Buy
+34,385
New +$694K 0.02% 826

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Walleye Capital's PAHC Position: Q2 2026 in Review

Walleye Capital sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 27,755 shares — an estimated $1.54M sold.

Walleye Capital first reported a position in PAHC in Q1 2022 and held it in 11 quarters. The position peaked at $2.47M in Q4 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Walleye Capital reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 27,755 Phibro Animal Health shares in Q2 2026, an estimated $1.54M.
  • Walleye Capital first reported a position in Phibro Animal Health in Q1 2022 and held it in 11 quarters.
  • Walleye Capital's Phibro Animal Health position peaked at $2.47M in Q4 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.